Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by cavinsin on Mar 28, 2016 3:56pm

ProMetic

PLI now second biggest pharma in Canada by Market Cap, surpassing CXR by couple of hundreds on millions, not for long although.. Stockcoach1 check you PM
Comment by argentia77 on Mar 28, 2016 5:02pm
And after 23 years in business PLI still pays no dividend and has negative eps. The stock market is hard to understand sometimes. 
Comment by cavinsin on Mar 28, 2016 6:50pm
Sure is, that's for sure, Just look at CXR, However, shorting this stock is like throwing your money away, There will be panic short covering at no distant future, just wait, last laugh is the sweetest laugh.
Comment by wolfy2424 on Mar 28, 2016 7:02pm
Prometic is in a completely different business and has spent millions in developing their plasma protein business For those in the know about Prometic you will see this company sky rocket in earnings in the next 5 years  Very misunderstood company and their technology is going to have an incredible impact on many sick/ailing patients globally 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities